Impact of add-on medications on patient‘s satisfaction in patients with asthma

Y. Oshita, T. Koga, T. Kamimura, H. Aizawa (Kurume, Japan)

Source: Annual Congress 2005 - Asthma management II
Session: Asthma management II
Session type: Thematic Poster Session
Number: 1836
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Oshita, T. Koga, T. Kamimura, H. Aizawa (Kurume, Japan). Impact of add-on medications on patient‘s satisfaction in patients with asthma. Eur Respir J 2005; 26: Suppl. 49, 1836

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Satisfaction with inhaled asthma medication and patients quality of life
Source: Eur Respir J 2004; 24: Suppl. 48, 285s
Year: 2004

Combination asthma medication and healthcare use in severe or difficult-to-treat asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Attitudes to inhaler devices are associated with self-reported adherence to asthma therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 840s
Year: 2006

Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013

Symptom pattern and treatment for people non-compliant with asthma medication
Source: Annual Congress 2005 - Allergic rhinitis and asthma in primary care
Year: 2005


Self-care behavior for medications use and treatment outcome in elderly with asthma
Source: Annual Congress 2010 - Dysfunctional breathing, asthma and respiratory physiotherapy problems
Year: 2010


What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance
Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020
Year: 2021



Effect of asthma and asthma medication on the prognosis of patients with COVID-19
Source: Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020
Year: 2021



Measures of adherence in patients with severe asthma prescribed systemic steroids in the U-BIOPRED cohort
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018


Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

Factors influencing medication adherence amongst difficult-to-treat asthma patients
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017


Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients
Source: Eur Respir J, 53 (6) 1801824; 10.1183/13993003.01824-2018
Year: 2019



High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs
Source: Eur Respir J 2012; 40: 1149-1155
Year: 2012



Safety profile of tiotropium add-on therapy in paediatric patients by gender
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018



Patients with moderate asthma symptoms may benefit from short-term inhaled corticosteroid monotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 615s
Year: 2007

Impact of omalizumab in patients with severe asthma
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009

Budesonide/formoterol maintenance and reliever therapy use in elderly asthma patients
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010

Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Efficacy of ruzam in the treatment of patients with mild-to-moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004